nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—CYP3A4—bone cancer	0.421	1	CbGaD
Hydrocortisone—ABCG2—Carboplatin—bone cancer	0.0723	0.219	CbGbCtD
Hydrocortisone—ABCG2—Cisplatin—bone cancer	0.0618	0.187	CbGbCtD
Hydrocortisone—SLCO1A2—Methotrexate—bone cancer	0.0535	0.162	CbGbCtD
Hydrocortisone—ABCG2—Doxorubicin—bone cancer	0.0414	0.126	CbGbCtD
Hydrocortisone—ABCG2—Methotrexate—bone cancer	0.0401	0.122	CbGbCtD
Hydrocortisone—ABCB1—Cisplatin—bone cancer	0.0223	0.0676	CbGbCtD
Hydrocortisone—ABCB1—Doxorubicin—bone cancer	0.0149	0.0453	CbGbCtD
Hydrocortisone—ABCB1—Methotrexate—bone cancer	0.0145	0.0439	CbGbCtD
Hydrocortisone—CYP3A4—Doxorubicin—bone cancer	0.00894	0.0271	CbGbCtD
Hydrocortisone—CYP3A7—Xenobiotics—CYP3A4—bone cancer	0.000877	0.0105	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—FEV—bone cancer	0.00087	0.0105	CbGpPWpGaD
Hydrocortisone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000859	0.0103	CbGpPWpGaD
Hydrocortisone—CYP11B2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000847	0.0102	CbGpPWpGaD
Hydrocortisone—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.000843	0.0101	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (q) signalling events—GRM1—bone cancer	0.000806	0.00969	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metapathway biotransformation—CYP4V2—bone cancer	0.000782	0.00939	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—RGS1—bone cancer	0.000775	0.00931	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—GRM4—bone cancer	0.000775	0.00931	CbGpPWpGaD
Hydrocortisone—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00074	0.00889	CbGpPWpGaD
Hydrocortisone—CYP11B1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00073	0.00877	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000721	0.00867	CbGpPWpGaD
Hydrocortisone—NR3C1—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.000721	0.00866	CbGpPWpGaD
Hydrocortisone—ABCG2—Fluoropyrimidine Activity—DHFR—bone cancer	0.000699	0.0084	CbGpPWpGaD
Hydrocortisone—CYP11B2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000696	0.00836	CbGpPWpGaD
Hydrocortisone—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.00066	0.00793	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000657	0.00789	CbGpPWpGaD
Hydrocortisone—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.000634	0.00762	CbGpPWpGaD
Hydrocortisone—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000611	0.00734	CbGpPWpGaD
Hydrocortisone—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.00061	0.00732	CbGpPWpGaD
Hydrocortisone—CYP11B1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.0006	0.00721	CbGpPWpGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—GNA11—bone cancer	0.00058	0.00697	CbGpPWpGaD
Hydrocortisone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000574	0.0069	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.000573	0.00689	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000565	0.00679	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000559	0.00671	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000551	0.00663	CbGpPWpGaD
Hydrocortisone—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.000549	0.0066	CbGpPWpGaD
Hydrocortisone—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000545	0.00654	CbGpPWpGaD
Hydrocortisone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000535	0.00643	CbGpPWpGaD
Hydrocortisone—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.000528	0.00634	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (q) signalling events—GNA11—bone cancer	0.00052	0.00624	CbGpPWpGaD
Hydrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—bone cancer	0.000509	0.00611	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000509	0.00611	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.00049	0.00588	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.000478	0.00574	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—GRM4—bone cancer	0.000469	0.00564	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000467	0.00561	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000465	0.00558	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000463	0.00557	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000457	0.00549	CbGpPWpGaD
Hydrocortisone—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000435	0.00523	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—CDK4—bone cancer	0.000422	0.00507	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—GRM1—bone cancer	0.000407	0.00489	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000387	0.00465	CbGpPWpGaD
Hydrocortisone—CYP11B2—Biological oxidations—CYP3A4—bone cancer	0.00037	0.00444	CbGpPWpGaD
Hydrocortisone—Hydrocortamate—CYP3A4—bone cancer	0.00037	0.0604	CrCbGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—ZNF77—bone cancer	0.000368	0.00442	CbGpPWpGaD
Hydrocortisone—NR3C1—Endoderm Differentiation—EZH2—bone cancer	0.000367	0.00441	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—RB1—bone cancer	0.000367	0.00441	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metapathway biotransformation—CYP3A4—bone cancer	0.000365	0.00438	CbGpPWpGaD
Hydrocortisone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000364	0.00437	CbGpPWpGaD
Hydrocortisone—Cortisone acetate—CYP3A4—bone cancer	0.000364	0.0594	CrCbGaD
Hydrocortisone—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000359	0.00432	CbGpPWpGaD
Hydrocortisone—Arrhythmia—Cisplatin—bone cancer	0.000354	0.0022	CcSEcCtD
Hydrocortisone—Neuropathy—Doxorubicin—bone cancer	0.000352	0.00219	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000347	0.00416	CbGpPWpGaD
Hydrocortisone—Dry eye—Doxorubicin—bone cancer	0.000346	0.00216	CcSEcCtD
Hydrocortisone—Erythema—Cisplatin—bone cancer	0.000345	0.00215	CcSEcCtD
Hydrocortisone—Malnutrition—Cisplatin—bone cancer	0.000345	0.00215	CcSEcCtD
Hydrocortisone—Budesonide—CYP3A4—bone cancer	0.000344	0.0561	CrCbGaD
Hydrocortisone—Oesophagitis—Doxorubicin—bone cancer	0.000342	0.00213	CcSEcCtD
Hydrocortisone—Rash maculo-papular—Doxorubicin—bone cancer	0.00034	0.00212	CcSEcCtD
Hydrocortisone—Thrombophlebitis—Epirubicin—bone cancer	0.000339	0.00211	CcSEcCtD
Hydrocortisone—Ecchymosis—Doxorubicin—bone cancer	0.000339	0.00211	CcSEcCtD
Hydrocortisone—Diabetes mellitus—Epirubicin—bone cancer	0.000338	0.0021	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Doxorubicin—bone cancer	0.000333	0.00208	CcSEcCtD
Hydrocortisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00033	0.00396	CbGpPWpGaD
Hydrocortisone—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000328	0.00395	CbGpPWpGaD
Hydrocortisone—Eczema—Epirubicin—bone cancer	0.000327	0.00204	CcSEcCtD
Hydrocortisone—Anaphylactoid reaction—Methotrexate—bone cancer	0.000324	0.00202	CcSEcCtD
Hydrocortisone—Cardiac failure congestive—Epirubicin—bone cancer	0.000324	0.00202	CcSEcCtD
Hydrocortisone—Lethargy—Methotrexate—bone cancer	0.00032	0.002	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Cisplatin—bone cancer	0.00032	0.00199	CcSEcCtD
Hydrocortisone—Eplerenone—CYP3A4—bone cancer	0.000319	0.0522	CrCbGaD
Hydrocortisone—CYP11B1—Biological oxidations—CYP3A4—bone cancer	0.000319	0.00383	CbGpPWpGaD
Hydrocortisone—CYP11B2—Biological oxidations—GSTP1—bone cancer	0.000316	0.0038	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metapathway biotransformation—CYP3A4—bone cancer	0.000314	0.00378	CbGpPWpGaD
Hydrocortisone—Thrombophlebitis—Doxorubicin—bone cancer	0.000314	0.00196	CcSEcCtD
Hydrocortisone—Osteoarthritis—Methotrexate—bone cancer	0.000314	0.00196	CcSEcCtD
Hydrocortisone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000313	0.00376	CbGpPWpGaD
Hydrocortisone—Increased appetite—Epirubicin—bone cancer	0.000313	0.00195	CcSEcCtD
Hydrocortisone—Diabetes mellitus—Doxorubicin—bone cancer	0.000313	0.00195	CcSEcCtD
Hydrocortisone—CYP11B2—Metapathway biotransformation—GSTP1—bone cancer	0.000312	0.00375	CbGpPWpGaD
Hydrocortisone—Malaise—Cisplatin—bone cancer	0.000311	0.00194	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000307	0.00368	CbGpPWpGaD
Hydrocortisone—Anaphylactoid reaction—Epirubicin—bone cancer	0.000304	0.00189	CcSEcCtD
Hydrocortisone—Eczema—Doxorubicin—bone cancer	0.000302	0.00188	CcSEcCtD
Hydrocortisone—ANXA1—Spinal Cord Injury—PTGS2—bone cancer	0.000302	0.00362	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000301	0.00362	CbGpPWpGaD
Hydrocortisone—Cardiac failure—Epirubicin—bone cancer	0.000301	0.00188	CcSEcCtD
Hydrocortisone—Drospirenone—PTGS2—bone cancer	0.0003	0.049	CrCbGaD
Hydrocortisone—Lethargy—Epirubicin—bone cancer	0.0003	0.00187	CcSEcCtD
Hydrocortisone—Cardiac failure congestive—Doxorubicin—bone cancer	0.0003	0.00187	CcSEcCtD
Hydrocortisone—Irritability—Methotrexate—bone cancer	0.0003	0.00187	CcSEcCtD
Hydrocortisone—Convulsion—Cisplatin—bone cancer	0.000299	0.00186	CcSEcCtD
Hydrocortisone—Mood swings—Methotrexate—bone cancer	0.000297	0.00185	CcSEcCtD
Hydrocortisone—Alclometasone—CYP3A4—bone cancer	0.000296	0.0484	CrCbGaD
Hydrocortisone—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000295	0.00355	CbGpPWpGaD
Hydrocortisone—Osteoarthritis—Epirubicin—bone cancer	0.000294	0.00183	CcSEcCtD
Hydrocortisone—Myalgia—Cisplatin—bone cancer	0.000293	0.00183	CcSEcCtD
Hydrocortisone—Anxiety—Cisplatin—bone cancer	0.000292	0.00182	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000291	0.00182	CcSEcCtD
Hydrocortisone—Discomfort—Cisplatin—bone cancer	0.00029	0.00181	CcSEcCtD
Hydrocortisone—Increased appetite—Doxorubicin—bone cancer	0.000289	0.0018	CcSEcCtD
Hydrocortisone—Affect lability—Epirubicin—bone cancer	0.000289	0.0018	CcSEcCtD
Hydrocortisone—Flunisolide—CYP3A4—bone cancer	0.000288	0.0471	CrCbGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—BRAF—bone cancer	0.000288	0.00346	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000287	0.00345	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—SMO—bone cancer	0.000287	0.00344	CbGpPWpGaD
Hydrocortisone—Paramethasone—CYP3A4—bone cancer	0.000285	0.0465	CrCbGaD
Hydrocortisone—Anaphylactic shock—Cisplatin—bone cancer	0.000281	0.00175	CcSEcCtD
Hydrocortisone—Oedema—Cisplatin—bone cancer	0.000281	0.00175	CcSEcCtD
Hydrocortisone—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000281	0.00175	CcSEcCtD
Hydrocortisone—Ciclesonide—CYP3A4—bone cancer	0.00028	0.0457	CrCbGaD
Hydrocortisone—Cardiac arrest—Epirubicin—bone cancer	0.000279	0.00174	CcSEcCtD
Hydrocortisone—Infection—Cisplatin—bone cancer	0.000279	0.00174	CcSEcCtD
Hydrocortisone—Cardiac failure—Doxorubicin—bone cancer	0.000279	0.00174	CcSEcCtD
Hydrocortisone—Mood swings—Epirubicin—bone cancer	0.000278	0.00173	CcSEcCtD
Hydrocortisone—Fluorometholone—CYP3A4—bone cancer	0.000278	0.0454	CrCbGaD
Hydrocortisone—Lethargy—Doxorubicin—bone cancer	0.000277	0.00173	CcSEcCtD
Hydrocortisone—Nervous system disorder—Cisplatin—bone cancer	0.000276	0.00172	CcSEcCtD
Hydrocortisone—Tachycardia—Cisplatin—bone cancer	0.000274	0.00171	CcSEcCtD
Hydrocortisone—Skin disorder—Cisplatin—bone cancer	0.000273	0.0017	CcSEcCtD
Hydrocortisone—CYP11B1—Biological oxidations—GSTP1—bone cancer	0.000272	0.00327	CbGpPWpGaD
Hydrocortisone—Osteoarthritis—Doxorubicin—bone cancer	0.000272	0.00169	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Cisplatin—bone cancer	0.000272	0.00169	CcSEcCtD
Hydrocortisone—Dry skin—Epirubicin—bone cancer	0.000269	0.00168	CcSEcCtD
Hydrocortisone—CYP11B1—Metapathway biotransformation—GSTP1—bone cancer	0.000269	0.00323	CbGpPWpGaD
Hydrocortisone—Methylprednisolone—CYP3A4—bone cancer	0.000269	0.0439	CrCbGaD
Hydrocortisone—Abdominal pain upper—Epirubicin—bone cancer	0.000268	0.00167	CcSEcCtD
Hydrocortisone—Anorexia—Cisplatin—bone cancer	0.000268	0.00167	CcSEcCtD
Hydrocortisone—Affect lability—Doxorubicin—bone cancer	0.000268	0.00167	CcSEcCtD
Hydrocortisone—Hypokalaemia—Epirubicin—bone cancer	0.000267	0.00167	CcSEcCtD
Hydrocortisone—Pancreatitis—Methotrexate—bone cancer	0.000266	0.00166	CcSEcCtD
Hydrocortisone—ANXA1—GPCR downstream signaling—GRM4—bone cancer	0.000265	0.00318	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—RGS1—bone cancer	0.000265	0.00318	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—MMP9—bone cancer	0.000265	0.00318	CbGpPWpGaD
Hydrocortisone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000263	0.00316	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000263	0.00316	CbGpPWpGaD
Hydrocortisone—Hypotension—Cisplatin—bone cancer	0.000263	0.00164	CcSEcCtD
Hydrocortisone—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00026	0.00312	CbGpPWpGaD
Hydrocortisone—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000259	0.00161	CcSEcCtD
Hydrocortisone—Muscular weakness—Epirubicin—bone cancer	0.000259	0.00161	CcSEcCtD
Hydrocortisone—Cardiac arrest—Doxorubicin—bone cancer	0.000258	0.00161	CcSEcCtD
Hydrocortisone—Mood swings—Doxorubicin—bone cancer	0.000258	0.0016	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.000257	0.00309	CbGpPWpGaD
Hydrocortisone—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000256	0.0016	CcSEcCtD
Hydrocortisone—Abdominal distension—Epirubicin—bone cancer	0.000256	0.00159	CcSEcCtD
Hydrocortisone—Paraesthesia—Cisplatin—bone cancer	0.000252	0.00157	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Methotrexate—bone cancer	0.000252	0.00157	CcSEcCtD
Hydrocortisone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000252	0.00303	CbGpPWpGaD
Hydrocortisone—Levonorgestrel—CYP3A4—bone cancer	0.00025	0.0408	CrCbGaD
Hydrocortisone—Dry skin—Doxorubicin—bone cancer	0.000249	0.00155	CcSEcCtD
Hydrocortisone—Pancreatitis—Epirubicin—bone cancer	0.000249	0.00155	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Doxorubicin—bone cancer	0.000248	0.00155	CcSEcCtD
Hydrocortisone—Hypokalaemia—Doxorubicin—bone cancer	0.000247	0.00154	CcSEcCtD
Hydrocortisone—Decreased appetite—Cisplatin—bone cancer	0.000244	0.00152	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Cisplatin—bone cancer	0.000243	0.00151	CcSEcCtD
Hydrocortisone—Infestation NOS—Methotrexate—bone cancer	0.000242	0.00151	CcSEcCtD
Hydrocortisone—Infestation—Methotrexate—bone cancer	0.000242	0.00151	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—RGS1—bone cancer	0.000241	0.00289	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—GRM4—bone cancer	0.000241	0.00289	CbGpPWpGaD
Hydrocortisone—Pain—Cisplatin—bone cancer	0.00024	0.0015	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00024	0.00149	CcSEcCtD
Hydrocortisone—Muscular weakness—Doxorubicin—bone cancer	0.00024	0.00149	CcSEcCtD
Hydrocortisone—Abdominal distension—Doxorubicin—bone cancer	0.000237	0.00147	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Epirubicin—bone cancer	0.000236	0.00147	CcSEcCtD
Hydrocortisone—Feeling abnormal—Cisplatin—bone cancer	0.000232	0.00144	CcSEcCtD
Hydrocortisone—Weight increased—Epirubicin—bone cancer	0.000231	0.00144	CcSEcCtD
Hydrocortisone—Pancreatitis—Doxorubicin—bone cancer	0.00023	0.00144	CcSEcCtD
Hydrocortisone—ANXA1—GPCR downstream signaling—GRM1—bone cancer	0.00023	0.00276	CbGpPWpGaD
Hydrocortisone—Weight decreased—Epirubicin—bone cancer	0.00023	0.00143	CcSEcCtD
Hydrocortisone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000228	0.00274	CbGpPWpGaD
Hydrocortisone—Danazol—CYP3A4—bone cancer	0.000228	0.0372	CrCbGaD
Hydrocortisone—Triamcinolone—CYP3A4—bone cancer	0.000227	0.037	CrCbGaD
Hydrocortisone—Infestation NOS—Epirubicin—bone cancer	0.000226	0.00141	CcSEcCtD
Hydrocortisone—Infestation—Epirubicin—bone cancer	0.000226	0.00141	CcSEcCtD
Hydrocortisone—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000225	0.0027	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—JUN—bone cancer	0.000223	0.00268	CbGpPWpGaD
Hydrocortisone—Body temperature increased—Cisplatin—bone cancer	0.000222	0.00139	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Epirubicin—bone cancer	0.000222	0.00138	CcSEcCtD
Hydrocortisone—Triamcinolone—PTGS2—bone cancer	0.000222	0.0362	CrCbGaD
Hydrocortisone—CYP11B2—Metabolism—NDUFA12—bone cancer	0.000222	0.00266	CbGpPWpGaD
Hydrocortisone—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000218	0.00136	CcSEcCtD
Hydrocortisone—Haemoglobin—Methotrexate—bone cancer	0.000218	0.00136	CcSEcCtD
Hydrocortisone—Haemorrhage—Methotrexate—bone cancer	0.000217	0.00135	CcSEcCtD
Hydrocortisone—NR3C1—AP-1 transcription factor network—PLAU—bone cancer	0.000214	0.00258	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—EGFR—bone cancer	0.000214	0.00257	CbGpPWpGaD
Hydrocortisone—Weight increased—Doxorubicin—bone cancer	0.000214	0.00133	CcSEcCtD
Hydrocortisone—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000213	0.00256	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000213	0.00256	CbGpPWpGaD
Hydrocortisone—Weight decreased—Doxorubicin—bone cancer	0.000213	0.00132	CcSEcCtD
Hydrocortisone—Infestation—Doxorubicin—bone cancer	0.000209	0.00131	CcSEcCtD
Hydrocortisone—Infestation NOS—Doxorubicin—bone cancer	0.000209	0.00131	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—GRM1—bone cancer	0.000209	0.00251	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Cisplatin—bone cancer	0.000207	0.00129	CcSEcCtD
Hydrocortisone—Bradycardia—Epirubicin—bone cancer	0.000207	0.00129	CcSEcCtD
Hydrocortisone—Prednisone—CYP3A4—bone cancer	0.000205	0.0336	CrCbGaD
Hydrocortisone—Neuropathy peripheral—Doxorubicin—bone cancer	0.000205	0.00128	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000205	0.00247	CbGpPWpGaD
Hydrocortisone—Medroxyprogesterone Acetate—CYP3A4—bone cancer	0.000204	0.0334	CrCbGaD
Hydrocortisone—Haemoglobin—Epirubicin—bone cancer	0.000204	0.00127	CcSEcCtD
Hydrocortisone—Haemorrhage—Epirubicin—bone cancer	0.000203	0.00127	CcSEcCtD
Hydrocortisone—Eye disorder—Methotrexate—bone cancer	0.000203	0.00126	CcSEcCtD
Hydrocortisone—Norethindrone—CYP3A4—bone cancer	0.000203	0.0331	CrCbGaD
Hydrocortisone—Asthenia—Cisplatin—bone cancer	0.000202	0.00126	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Epirubicin—bone cancer	0.0002	0.00124	CcSEcCtD
Hydrocortisone—Immune system disorder—Methotrexate—bone cancer	0.000196	0.00122	CcSEcCtD
Hydrocortisone—Diarrhoea—Cisplatin—bone cancer	0.000192	0.0012	CcSEcCtD
Hydrocortisone—Methyltestosterone—CYP3A4—bone cancer	0.000192	0.0314	CrCbGaD
Hydrocortisone—Bradycardia—Doxorubicin—bone cancer	0.000191	0.00119	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism—NDUFA12—bone cancer	0.000191	0.00229	CbGpPWpGaD
Hydrocortisone—Mental disorder—Methotrexate—bone cancer	0.00019	0.00119	CcSEcCtD
Hydrocortisone—Eye disorder—Epirubicin—bone cancer	0.00019	0.00118	CcSEcCtD
Hydrocortisone—Prednisolone—CYP3A4—bone cancer	0.000189	0.0309	CrCbGaD
Hydrocortisone—Malnutrition—Methotrexate—bone cancer	0.000189	0.00118	CcSEcCtD
Hydrocortisone—Erythema—Methotrexate—bone cancer	0.000189	0.00118	CcSEcCtD
Hydrocortisone—Haemoglobin—Doxorubicin—bone cancer	0.000189	0.00118	CcSEcCtD
Hydrocortisone—Haemorrhage—Doxorubicin—bone cancer	0.000188	0.00117	CcSEcCtD
Hydrocortisone—NR3C1—Regulation of Androgen receptor activity—MDM2—bone cancer	0.000188	0.00225	CbGpPWpGaD
Hydrocortisone—Betamethasone—CYP3A4—bone cancer	0.000186	0.0303	CrCbGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000185	0.00222	CbGpPWpGaD
Hydrocortisone—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000185	0.00222	CbGpPWpGaD
Hydrocortisone—Connective tissue disorder—Doxorubicin—bone cancer	0.000185	0.00115	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism—NT5C3A—bone cancer	0.000184	0.00221	CbGpPWpGaD
Hydrocortisone—Immune system disorder—Epirubicin—bone cancer	0.000184	0.00114	CcSEcCtD
Hydrocortisone—Betamethasone—PTGS2—bone cancer	0.000182	0.0297	CrCbGaD
Hydrocortisone—Arrhythmia—Epirubicin—bone cancer	0.000182	0.00113	CcSEcCtD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.00018	0.00217	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—TP53—bone cancer	0.00018	0.00216	CbGpPWpGaD
Hydrocortisone—Vomiting—Cisplatin—bone cancer	0.000179	0.00111	CcSEcCtD
Hydrocortisone—Mental disorder—Epirubicin—bone cancer	0.000178	0.00111	CcSEcCtD
Hydrocortisone—Rash—Cisplatin—bone cancer	0.000177	0.0011	CcSEcCtD
Hydrocortisone—Dermatitis—Cisplatin—bone cancer	0.000177	0.0011	CcSEcCtD
Hydrocortisone—NR3C1—Gene Expression—ZNF77—bone cancer	0.000177	0.00213	CbGpPWpGaD
Hydrocortisone—Malnutrition—Epirubicin—bone cancer	0.000177	0.0011	CcSEcCtD
Hydrocortisone—Erythema—Epirubicin—bone cancer	0.000177	0.0011	CcSEcCtD
Hydrocortisone—Eye disorder—Doxorubicin—bone cancer	0.000176	0.0011	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.000176	0.00211	CbGpPWpGaD
Hydrocortisone—Ill-defined disorder—Methotrexate—bone cancer	0.000175	0.00109	CcSEcCtD
Hydrocortisone—Malaise—Methotrexate—bone cancer	0.00017	0.00106	CcSEcCtD
Hydrocortisone—Immune system disorder—Doxorubicin—bone cancer	0.00017	0.00106	CcSEcCtD
Hydrocortisone—Vertigo—Methotrexate—bone cancer	0.00017	0.00106	CcSEcCtD
Hydrocortisone—Arrhythmia—Doxorubicin—bone cancer	0.000168	0.00105	CcSEcCtD
Hydrocortisone—Nausea—Cisplatin—bone cancer	0.000167	0.00104	CcSEcCtD
Hydrocortisone—Mental disorder—Doxorubicin—bone cancer	0.000165	0.00103	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Epirubicin—bone cancer	0.000164	0.00102	CcSEcCtD
Hydrocortisone—Convulsion—Methotrexate—bone cancer	0.000164	0.00102	CcSEcCtD
Hydrocortisone—Erythema—Doxorubicin—bone cancer	0.000164	0.00102	CcSEcCtD
Hydrocortisone—Malnutrition—Doxorubicin—bone cancer	0.000164	0.00102	CcSEcCtD
Hydrocortisone—NR3C1—Regulation of Androgen receptor activity—JUN—bone cancer	0.000163	0.00196	CbGpPWpGaD
Hydrocortisone—Myalgia—Methotrexate—bone cancer	0.000161	0.001	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00016	0.000996	CcSEcCtD
Hydrocortisone—Malaise—Epirubicin—bone cancer	0.00016	0.000994	CcSEcCtD
Hydrocortisone—Discomfort—Methotrexate—bone cancer	0.000159	0.000991	CcSEcCtD
Hydrocortisone—Vertigo—Epirubicin—bone cancer	0.000159	0.000991	CcSEcCtD
Hydrocortisone—Syncope—Epirubicin—bone cancer	0.000159	0.000989	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism—NT5C3A—bone cancer	0.000158	0.0019	CbGpPWpGaD
Hydrocortisone—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000157	0.00188	CbGpPWpGaD
Hydrocortisone—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	0.000156	0.00188	CbGpPWpGaD
Hydrocortisone—Loss of consciousness—Epirubicin—bone cancer	0.000156	0.000969	CcSEcCtD
Hydrocortisone—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000155	0.00186	CbGpPWpGaD
Hydrocortisone—Anaphylactic shock—Methotrexate—bone cancer	0.000154	0.000962	CcSEcCtD
Hydrocortisone—Convulsion—Epirubicin—bone cancer	0.000153	0.000955	CcSEcCtD
Hydrocortisone—Infection—Methotrexate—bone cancer	0.000153	0.000955	CcSEcCtD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000153	0.00184	CbGpPWpGaD
Hydrocortisone—Hypertension—Epirubicin—bone cancer	0.000153	0.000952	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Doxorubicin—bone cancer	0.000152	0.000947	CcSEcCtD
Hydrocortisone—Nervous system disorder—Methotrexate—bone cancer	0.000151	0.000943	CcSEcCtD
Hydrocortisone—Myalgia—Epirubicin—bone cancer	0.000151	0.000939	CcSEcCtD
Hydrocortisone—Anxiety—Epirubicin—bone cancer	0.00015	0.000935	CcSEcCtD
Hydrocortisone—Skin disorder—Methotrexate—bone cancer	0.00015	0.000934	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00015	0.000932	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Methotrexate—bone cancer	0.000149	0.00093	CcSEcCtD
Hydrocortisone—Discomfort—Epirubicin—bone cancer	0.000149	0.000927	CcSEcCtD
Hydrocortisone—ANXA1—GPCR downstream signaling—GNA11—bone cancer	0.000148	0.00178	CbGpPWpGaD
Hydrocortisone—Malaise—Doxorubicin—bone cancer	0.000148	0.00092	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—TP53—bone cancer	0.000147	0.00177	CbGpPWpGaD
Hydrocortisone—Vertigo—Doxorubicin—bone cancer	0.000147	0.000917	CcSEcCtD
Hydrocortisone—Anorexia—Methotrexate—bone cancer	0.000147	0.000917	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—SMO—bone cancer	0.000147	0.00177	CbGpPWpGaD
Hydrocortisone—Syncope—Doxorubicin—bone cancer	0.000147	0.000915	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000145	0.00175	CbGpPWpGaD
Hydrocortisone—Anaphylactic shock—Epirubicin—bone cancer	0.000144	0.0009	CcSEcCtD
Hydrocortisone—Oedema—Epirubicin—bone cancer	0.000144	0.0009	CcSEcCtD
Hydrocortisone—Hypotension—Methotrexate—bone cancer	0.000144	0.000898	CcSEcCtD
Hydrocortisone—Loss of consciousness—Doxorubicin—bone cancer	0.000144	0.000897	CcSEcCtD
Hydrocortisone—Infection—Epirubicin—bone cancer	0.000143	0.000894	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—RGS1—bone cancer	0.000142	0.00171	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—GRM4—bone cancer	0.000142	0.00171	CbGpPWpGaD
Hydrocortisone—Shock—Epirubicin—bone cancer	0.000142	0.000885	CcSEcCtD
Hydrocortisone—Convulsion—Doxorubicin—bone cancer	0.000142	0.000884	CcSEcCtD
Hydrocortisone—Nervous system disorder—Epirubicin—bone cancer	0.000142	0.000882	CcSEcCtD
Hydrocortisone—Hypertension—Doxorubicin—bone cancer	0.000141	0.000881	CcSEcCtD
Hydrocortisone—Tachycardia—Epirubicin—bone cancer	0.000141	0.000878	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000141	0.000876	CcSEcCtD
Hydrocortisone—Skin disorder—Epirubicin—bone cancer	0.00014	0.000874	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Epirubicin—bone cancer	0.00014	0.00087	CcSEcCtD
Hydrocortisone—Insomnia—Methotrexate—bone cancer	0.00014	0.00087	CcSEcCtD
Hydrocortisone—Myalgia—Doxorubicin—bone cancer	0.000139	0.000868	CcSEcCtD
Hydrocortisone—Anxiety—Doxorubicin—bone cancer	0.000139	0.000865	CcSEcCtD
Hydrocortisone—Paraesthesia—Methotrexate—bone cancer	0.000139	0.000863	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000138	0.000863	CcSEcCtD
Hydrocortisone—Discomfort—Doxorubicin—bone cancer	0.000138	0.000858	CcSEcCtD
Hydrocortisone—Anorexia—Epirubicin—bone cancer	0.000138	0.000858	CcSEcCtD
Hydrocortisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000136	0.00164	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000136	0.00163	CbGpPWpGaD
Hydrocortisone—Dyspepsia—Methotrexate—bone cancer	0.000136	0.000846	CcSEcCtD
Hydrocortisone—Hypotension—Epirubicin—bone cancer	0.000135	0.000841	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—GNA11—bone cancer	0.000134	0.00162	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—IL3—bone cancer	0.000134	0.00161	CbGpPWpGaD
Hydrocortisone—Decreased appetite—Methotrexate—bone cancer	0.000134	0.000836	CcSEcCtD
Hydrocortisone—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000134	0.00161	CbGpPWpGaD
Hydrocortisone—Oedema—Doxorubicin—bone cancer	0.000134	0.000833	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Doxorubicin—bone cancer	0.000134	0.000833	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Methotrexate—bone cancer	0.000133	0.00083	CcSEcCtD
Hydrocortisone—Fatigue—Methotrexate—bone cancer	0.000133	0.000829	CcSEcCtD
Hydrocortisone—Infection—Doxorubicin—bone cancer	0.000133	0.000827	CcSEcCtD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000132	0.00159	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—bone cancer	0.000132	0.00159	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000132	0.00159	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000132	0.00159	CbGpPWpGaD
Hydrocortisone—Pain—Methotrexate—bone cancer	0.000132	0.000822	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000132	0.00082	CcSEcCtD
Hydrocortisone—Shock—Doxorubicin—bone cancer	0.000131	0.000819	CcSEcCtD
Hydrocortisone—Nervous system disorder—Doxorubicin—bone cancer	0.000131	0.000816	CcSEcCtD
Hydrocortisone—Insomnia—Epirubicin—bone cancer	0.000131	0.000814	CcSEcCtD
Hydrocortisone—NR3C1—AP-1 transcription factor network—JUN—bone cancer	0.000131	0.00157	CbGpPWpGaD
Hydrocortisone—Tachycardia—Doxorubicin—bone cancer	0.00013	0.000813	CcSEcCtD
Hydrocortisone—Skin disorder—Doxorubicin—bone cancer	0.00013	0.000809	CcSEcCtD
Hydrocortisone—Paraesthesia—Epirubicin—bone cancer	0.00013	0.000808	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Doxorubicin—bone cancer	0.000129	0.000805	CcSEcCtD
Hydrocortisone—Anorexia—Doxorubicin—bone cancer	0.000127	0.000794	CcSEcCtD
Hydrocortisone—Feeling abnormal—Methotrexate—bone cancer	0.000127	0.000792	CcSEcCtD
Hydrocortisone—Dyspepsia—Epirubicin—bone cancer	0.000127	0.000792	CcSEcCtD
Hydrocortisone—NR3C1—AP-1 transcription factor network—MMP9—bone cancer	0.000127	0.00153	CbGpPWpGaD
Hydrocortisone—Gastrointestinal pain—Methotrexate—bone cancer	0.000126	0.000786	CcSEcCtD
Hydrocortisone—Decreased appetite—Epirubicin—bone cancer	0.000126	0.000782	CcSEcCtD
Hydrocortisone—Hypotension—Doxorubicin—bone cancer	0.000125	0.000778	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Epirubicin—bone cancer	0.000125	0.000777	CcSEcCtD
Hydrocortisone—Fatigue—Epirubicin—bone cancer	0.000124	0.000776	CcSEcCtD
Hydrocortisone—NR3C1—Generic Transcription Pathway—NR1I2—bone cancer	0.000124	0.0015	CbGpPWpGaD
Hydrocortisone—Pain—Epirubicin—bone cancer	0.000123	0.000769	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—GRM1—bone cancer	0.000123	0.00148	CbGpPWpGaD
Hydrocortisone—Urticaria—Methotrexate—bone cancer	0.000123	0.000764	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000122	0.00147	CbGpPWpGaD
Hydrocortisone—Abdominal pain—Methotrexate—bone cancer	0.000122	0.00076	CcSEcCtD
Hydrocortisone—Body temperature increased—Methotrexate—bone cancer	0.000122	0.00076	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—IL3—bone cancer	0.000122	0.00146	CbGpPWpGaD
Hydrocortisone—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000122	0.000759	CcSEcCtD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000121	0.00146	CbGpPWpGaD
Hydrocortisone—Insomnia—Doxorubicin—bone cancer	0.000121	0.000753	CcSEcCtD
Hydrocortisone—Paraesthesia—Doxorubicin—bone cancer	0.00012	0.000748	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism—NDUFA12—bone cancer	0.00012	0.00144	CbGpPWpGaD
Hydrocortisone—Feeling abnormal—Epirubicin—bone cancer	0.000119	0.000741	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Epirubicin—bone cancer	0.000118	0.000736	CcSEcCtD
Hydrocortisone—Progesterone—CYP3A4—bone cancer	0.000118	0.0193	CrCbGaD
Hydrocortisone—Dyspepsia—Doxorubicin—bone cancer	0.000118	0.000733	CcSEcCtD
Hydrocortisone—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000117	0.0014	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.000116	0.0014	CbGpPWpGaD
Hydrocortisone—Decreased appetite—Doxorubicin—bone cancer	0.000116	0.000724	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000115	0.000719	CcSEcCtD
Hydrocortisone—Fatigue—Doxorubicin—bone cancer	0.000115	0.000718	CcSEcCtD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—JUN—bone cancer	0.000115	0.00138	CbGpPWpGaD
Hydrocortisone—Urticaria—Epirubicin—bone cancer	0.000115	0.000715	CcSEcCtD
Hydrocortisone—Pain—Doxorubicin—bone cancer	0.000114	0.000712	CcSEcCtD
Hydrocortisone—Abdominal pain—Epirubicin—bone cancer	0.000114	0.000711	CcSEcCtD
Hydrocortisone—Body temperature increased—Epirubicin—bone cancer	0.000114	0.000711	CcSEcCtD
Hydrocortisone—Hypersensitivity—Methotrexate—bone cancer	0.000114	0.000708	CcSEcCtD
Hydrocortisone—CYP3A5—Biological oxidations—CYP3A4—bone cancer	0.000113	0.00136	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	0.000112	0.00134	CbGpPWpGaD
Hydrocortisone—Testosterone—CYP3A4—bone cancer	0.000112	0.0182	CrCbGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000112	0.00134	CbGpPWpGaD
Hydrocortisone—Asthenia—Methotrexate—bone cancer	0.000111	0.00069	CcSEcCtD
Hydrocortisone—Feeling abnormal—Doxorubicin—bone cancer	0.00011	0.000686	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Doxorubicin—bone cancer	0.000109	0.000681	CcSEcCtD
Hydrocortisone—Pruritus—Methotrexate—bone cancer	0.000109	0.00068	CcSEcCtD
Hydrocortisone—Dexamethasone—CYP3A4—bone cancer	0.000108	0.0176	CrCbGaD
Hydrocortisone—NR3C1—Adipogenesis—RB1—bone cancer	0.000107	0.00129	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Epirubicin—bone cancer	0.000106	0.000663	CcSEcCtD
Hydrocortisone—Urticaria—Doxorubicin—bone cancer	0.000106	0.000661	CcSEcCtD
Hydrocortisone—Dexamethasone—PTGS2—bone cancer	0.000106	0.0173	CrCbGaD
Hydrocortisone—Abdominal pain—Doxorubicin—bone cancer	0.000106	0.000658	CcSEcCtD
Hydrocortisone—Body temperature increased—Doxorubicin—bone cancer	0.000106	0.000658	CcSEcCtD
Hydrocortisone—Diarrhoea—Methotrexate—bone cancer	0.000106	0.000658	CcSEcCtD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000105	0.00126	CbGpPWpGaD
Hydrocortisone—Asthenia—Epirubicin—bone cancer	0.000104	0.000646	CcSEcCtD
Hydrocortisone—Pruritus—Epirubicin—bone cancer	0.000102	0.000637	CcSEcCtD
Hydrocortisone—Dizziness—Methotrexate—bone cancer	0.000102	0.000636	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism—NT5C3A—bone cancer	9.92e-05	0.00119	CbGpPWpGaD
Hydrocortisone—Diarrhoea—Epirubicin—bone cancer	9.88e-05	0.000616	CcSEcCtD
Hydrocortisone—Hypersensitivity—Doxorubicin—bone cancer	9.84e-05	0.000613	CcSEcCtD
Hydrocortisone—CYP2C8—Biological oxidations—CYP3A4—bone cancer	9.82e-05	0.00118	CbGpPWpGaD
Hydrocortisone—Vomiting—Methotrexate—bone cancer	9.81e-05	0.000611	CcSEcCtD
Hydrocortisone—Rash—Methotrexate—bone cancer	9.73e-05	0.000606	CcSEcCtD
Hydrocortisone—Dermatitis—Methotrexate—bone cancer	9.72e-05	0.000606	CcSEcCtD
Hydrocortisone—CYP3A5—Biological oxidations—GSTP1—bone cancer	9.69e-05	0.00116	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	9.68e-05	0.00116	CbGpPWpGaD
Hydrocortisone—Headache—Methotrexate—bone cancer	9.67e-05	0.000602	CcSEcCtD
Hydrocortisone—Asthenia—Doxorubicin—bone cancer	9.59e-05	0.000597	CcSEcCtD
Hydrocortisone—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	9.56e-05	0.00115	CbGpPWpGaD
Hydrocortisone—Dizziness—Epirubicin—bone cancer	9.55e-05	0.000595	CcSEcCtD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	9.48e-05	0.00114	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—NDUFA12—bone cancer	9.48e-05	0.00114	CbGpPWpGaD
Hydrocortisone—Pruritus—Doxorubicin—bone cancer	9.45e-05	0.000589	CcSEcCtD
Hydrocortisone—CYP3A7—Metabolism—NDUFA12—bone cancer	9.4e-05	0.00113	CbGpPWpGaD
Hydrocortisone—Vomiting—Epirubicin—bone cancer	9.18e-05	0.000572	CcSEcCtD
Hydrocortisone—Nausea—Methotrexate—bone cancer	9.17e-05	0.000571	CcSEcCtD
Hydrocortisone—Diarrhoea—Doxorubicin—bone cancer	9.14e-05	0.00057	CcSEcCtD
Hydrocortisone—Rash—Epirubicin—bone cancer	9.1e-05	0.000567	CcSEcCtD
Hydrocortisone—Dermatitis—Epirubicin—bone cancer	9.1e-05	0.000567	CcSEcCtD
Hydrocortisone—Headache—Epirubicin—bone cancer	9.05e-05	0.000564	CcSEcCtD
Hydrocortisone—Dizziness—Doxorubicin—bone cancer	8.84e-05	0.000551	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—SMO—bone cancer	8.69e-05	0.00104	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—FUS—bone cancer	8.65e-05	0.00104	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	8.64e-05	0.00104	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—TP53—bone cancer	8.62e-05	0.00104	CbGpPWpGaD
Hydrocortisone—Nausea—Epirubicin—bone cancer	8.58e-05	0.000534	CcSEcCtD
Hydrocortisone—Vomiting—Doxorubicin—bone cancer	8.5e-05	0.000529	CcSEcCtD
Hydrocortisone—Rash—Doxorubicin—bone cancer	8.42e-05	0.000525	CcSEcCtD
Hydrocortisone—Dermatitis—Doxorubicin—bone cancer	8.42e-05	0.000524	CcSEcCtD
Hydrocortisone—CYP2C8—Biological oxidations—GSTP1—bone cancer	8.4e-05	0.00101	CbGpPWpGaD
Hydrocortisone—Headache—Doxorubicin—bone cancer	8.37e-05	0.000522	CcSEcCtD
Hydrocortisone—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	8.28e-05	0.000995	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—ENO2—bone cancer	8.04e-05	0.000966	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—GNA11—bone cancer	7.95e-05	0.000955	CbGpPWpGaD
Hydrocortisone—Nausea—Doxorubicin—bone cancer	7.94e-05	0.000495	CcSEcCtD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	7.86e-05	0.000945	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—NT5C3A—bone cancer	7.86e-05	0.000944	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—NT5C3A—bone cancer	7.79e-05	0.000936	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	7.76e-05	0.000932	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—bone cancer	7.59e-05	0.000912	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—DHFR—bone cancer	7.46e-05	0.000897	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—ATF1—bone cancer	7.39e-05	0.000887	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	7.35e-05	0.000883	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IL3—bone cancer	7.2e-05	0.000865	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—GNA11—bone cancer	6.97e-05	0.000838	CbGpPWpGaD
Hydrocortisone—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	6.96e-05	0.000836	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—ENO2—bone cancer	6.93e-05	0.000833	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—JUN—bone cancer	6.88e-05	0.000826	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—NDUFA12—bone cancer	6.79e-05	0.000816	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	6.57e-05	0.00079	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	6.56e-05	0.000788	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—DHFR—bone cancer	6.43e-05	0.000773	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—CYP3A4—bone cancer	6.32e-05	0.00076	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.29e-05	0.000756	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TGFBR2—bone cancer	6.16e-05	0.00074	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—GNA11—bone cancer	6.01e-05	0.000722	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—NR1I2—bone cancer	5.99e-05	0.00072	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—NDUFA12—bone cancer	5.88e-05	0.000707	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IGF1R—bone cancer	5.8e-05	0.000696	CbGpPWpGaD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	5.66e-05	0.00068	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—NT5C3A—bone cancer	5.63e-05	0.000676	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—CYP3A4—bone cancer	5.45e-05	0.000655	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5.42e-05	0.000651	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—GSTP1—bone cancer	5.41e-05	0.00065	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—NDUFA12—bone cancer	5.13e-05	0.000616	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.88e-05	0.000586	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—NT5C3A—bone cancer	4.88e-05	0.000586	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—GSTP1—bone cancer	4.66e-05	0.00056	CbGpPWpGaD
Hydrocortisone—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.51e-05	0.000541	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.44e-05	0.000534	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—EIF2S1—bone cancer	4.43e-05	0.000532	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ENO2—bone cancer	4.35e-05	0.000522	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—NT5C3A—bone cancer	4.25e-05	0.00051	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—KIT—bone cancer	4.2e-05	0.000505	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—DHFR—bone cancer	4.03e-05	0.000484	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—BRAF—bone cancer	3.95e-05	0.000475	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—EZH2—bone cancer	3.84e-05	0.000462	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—EGFR—bone cancer	3.83e-05	0.00046	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—GNA11—bone cancer	3.77e-05	0.000453	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.61e-05	0.000434	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.48e-05	0.000419	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ENO2—bone cancer	3.44e-05	0.000413	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CYP3A4—bone cancer	3.42e-05	0.00041	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ENO2—bone cancer	3.41e-05	0.00041	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.4e-05	0.000408	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MDM2—bone cancer	3.31e-05	0.000398	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—DHFR—bone cancer	3.19e-05	0.000384	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—DHFR—bone cancer	3.16e-05	0.00038	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—NDUFA12—bone cancer	3.16e-05	0.000379	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.14e-05	0.000377	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GNA11—bone cancer	2.98e-05	0.000359	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GNA11—bone cancer	2.96e-05	0.000355	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—GSTP1—bone cancer	2.92e-05	0.000351	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—JUN—bone cancer	2.88e-05	0.000346	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PTGS2—bone cancer	2.8e-05	0.000337	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MMP9—bone cancer	2.8e-05	0.000336	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CYP3A4—bone cancer	2.71e-05	0.000325	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CYP3A4—bone cancer	2.68e-05	0.000322	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—NT5C3A—bone cancer	2.62e-05	0.000314	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.47e-05	0.000297	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ENO2—bone cancer	2.47e-05	0.000296	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PTGS2—bone cancer	2.41e-05	0.00029	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—GSTP1—bone cancer	2.31e-05	0.000278	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—GSTP1—bone cancer	2.29e-05	0.000276	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—DHFR—bone cancer	2.29e-05	0.000275	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—EGFR—bone cancer	2.26e-05	0.000272	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GNA11—bone cancer	2.14e-05	0.000257	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ENO2—bone cancer	2.14e-05	0.000257	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.07e-05	0.000249	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—DHFR—bone cancer	1.98e-05	0.000238	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CYP3A4—bone cancer	1.94e-05	0.000233	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TP53—bone cancer	1.9e-05	0.000228	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ENO2—bone cancer	1.86e-05	0.000224	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GNA11—bone cancer	1.85e-05	0.000222	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—DHFR—bone cancer	1.73e-05	0.000207	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CYP3A4—bone cancer	1.68e-05	0.000202	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.67e-05	0.000201	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—GSTP1—bone cancer	1.66e-05	0.000199	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GNA11—bone cancer	1.61e-05	0.000194	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PTGS2—bone cancer	1.51e-05	0.000182	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CYP3A4—bone cancer	1.46e-05	0.000176	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—GSTP1—bone cancer	1.44e-05	0.000173	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—GSTP1—bone cancer	1.25e-05	0.00015	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PTGS2—bone cancer	1.2e-05	0.000144	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PTGS2—bone cancer	1.19e-05	0.000143	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ENO2—bone cancer	1.15e-05	0.000138	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—DHFR—bone cancer	1.06e-05	0.000128	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GNA11—bone cancer	9.94e-06	0.000119	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PTGS2—bone cancer	8.59e-06	0.000103	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—GSTP1—bone cancer	7.71e-06	9.26e-05	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PTGS2—bone cancer	7.44e-06	8.94e-05	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PTGS2—bone cancer	6.48e-06	7.79e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PTGS2—bone cancer	3.99e-06	4.8e-05	CbGpPWpGaD
